RHY
vs
S
S&P/ASX 300
RHY
Over the past 12 months, RHY has significantly outperformed S&P/ASX 300, delivering a return of +131% compared to the S&P/ASX 300's +8% growth.
Stocks Performance
RHY vs S&P/ASX 300
Performance Gap
RHY vs S&P/ASX 300
Performance By Year
RHY vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Rhythm Biosciences Ltd
Glance View
Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-12-07. The firm is engaged in developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. The Company’s development stage product, ColoSTAT focuses to provide early detection test for colorectal cancer. The Company’s ColoSTAT blood test is used to detect colorectal cancer at all stages, including the early ones. The firm's subsidiary includes Vision Tech Bio Pty Ltd.
